Bausch Health Announces the Unrestricting of Bausch + Lomb Under Bausch Health Debt Documents Pharmaceutical Investing
European Commission Grants Expanded Marketing Authorization for Gilead's Biktarvy® for the Treatment of HIV in Pediatric Populations Pharmaceutical Investing
Interim Data from Ambrx's Study of ARX788 selected for Spotlight Poster Discussion at the 2022 San Antonio Breast Cancer Symposium Life Science Investing
COMPASS Pathways to participate in upcoming Evercore ISI HealthCONx Conference Psychedelics Investing
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
